Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

445 ARTÍCULOS , VIENDO DEL 286 AL 300

D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care

Reuben DB, Gill TM, Stevens A, Williamson J, Volpi E, Lichtenstein M, Jennings LA, Tan Z, Evertson L, Bass D, Weitzman L, Carnie M, Wilson N, Araujo K, Charpentier P, Meng C, Greene EJ, Dziura J, Liu J, Unger E, Yang M, Currie K, Lenoir KM, Green AS, Abraham S, Vernon A, Samper-Ternent R, Raji M, Hirst RM, Galloway R, Finney GR, Ladd I, Rahm AK, Borek P, Peduzzi P.

J Am Geriatr Soc. 2020 Nov;68(11):2492-2499. doi: 10.1111/jgs.16862. Epub 2020 Oct 6.

The search for Alzheimer disease therapeutics - same targets, better trials?

Rafii MS, Aisen PS.

Nat Rev Neurol. 2020 Nov;16(11):597-598. doi: 10.1038/s41582-020-00414-3.

The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial

Delrieu J, Voisin T, Saint-Aubert L, Carrie I, Cantet C, Vellas B, Payoux P, Andrieu S.

Alzheimers Res Ther. 2020 Oct 19;12(1):134. doi: 10.1186/s13195-020-00683-6.

Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review

Muñoz-Jiménez M, Zaarkti A, García-Arnés JA, García-Casares N.

Dement Geriatr Cogn Disord. 2020;49(5):423-434. doi: 10.1159/000510677. Epub 2020 Oct 20.

Vitamins in Alzheimer's Disease-Review of the Latest Reports

Mielech A, Puścion-Jakubik A, Markiewicz-Żukowska R, Socha K.

Nutrients. 2020 Nov 11;12(11):3458. doi: 10.3390/nu12113458.

Recent Advances in Nanotechnology: A Novel Therapeutic System for the Treatment of Alzheimer's Disease

Chauhan PS, Yadav D, Koul B, Mohanta YK, Jin JO.

Curr Drug Metab. 2020;21(14):1144-1151. doi: 10.2174/1389200221666201124140518.

BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain

Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, Egan MF.

Brain. 2020 Dec 1;143(12):3816-3826. doi: 10.1093/brain/awaa332.

Rhizoma Coptidis for Alzheimer's Disease and Vascular Dementia: A Literature Review

Wang Z, Yang Y, Liu M, Wei Y, Liu J, Pei H, Li H.

Curr Vasc Pharmacol. 2020;18(4):358-368. doi: 10.2174/1570161117666190710151545.

Is Ongoing Anticholinergic Burden Associated With Greater Cognitive Decline and Dementia Severity in Mild to Moderate Alzheimer's Disease?

Dyer AH, Murphy C, Segurado R, Lawlor B, Kennelly SP; NILVAD Study Group.

J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5):987-994. doi: 10.1093/gerona/glz244.

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease

Liu CS, Herrmann N, Gallagher D, Rajji TK, Kiss A, Vieira D, Lanctôt KL.

J ECT. 2020 Sep;36(3):211-215. doi: 10.1097/YCT.0000000000000639.

Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway

Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP.

Inflammopharmacology. 2020 Apr;28(2):385-400. doi: 10.1007/s10787-019-00681-7. Epub 2020 Jan 3.

Efficacy and Safety of Psychostimulants for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kishi T, Sakuma K, Iwata N.

Pharmacopsychiatry. 2020 Apr;53(3):109-114. doi: 10.1055/a-1076-8228. Epub 2020 Jan 30.

Antiviral therapy: Valacyclovir Treatment of Alzheimer's Disease (VALAD) Trial: protocol for a randomised, double-blind,placebo-controlled, treatment trial

Devanand DP, Andrews H, Kreisl WC, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell KL, Pelton GH, Deliyannides D, Prasad KM, Huey ED.

BMJ Open. 2020 Feb 6;10(2):e032112. doi: 10.1136/bmjopen-2019-032112.

An evaluation of hydromethylthionine as a treatment option for Alzheimer's disease

Hashweh NN, Bartochowski Z, Khoury R, Grossberg GT.

Expert Opin Pharmacother. 2020 Apr;21(6):619-627. doi: 10.1080/14656566.2020.1719066. Epub 2020 Feb 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias